NFKB1 and neoplasm: Consistent with these observations, the expression levels of REL/NFκB transcription factors classified our ESR1-negative BRCA1 tumours in the same way as observed for the complete gene-set #2, with two main subclasses (a and b) that differed in the magnitude of expression change of immune response genes (but not in the direction) (Figure 3B).